Evertz Pharma added 100 Bitcoin worth over 10 million euros to its corporate treasury this week.
The company uses profits to buy Bitcoin as part of its long term financial and investment strategy.
Evertz Pharma sees Bitcoin as a key asset for building a strong and modern financial foundation.
Evertz Pharma GmbH, a German pharmaceutical company, has purchased 100 Bitcoin (BTC) treasury, worth 10 million euros (10.8 million US dollars). The new development is part of a long-term financial plan of the company to integrate Bitcoin as a principal reserve currency. This acquisition was announced through a June 11 press release.
https://twitter.com/evertz_dominik/status/1932815040408653892 Company Expands Crypto Portfolio
Evertz Pharma started investing in Bitcoin in 2020 by buying 2 million Euros worth of Bitcoins. The company has been accumulating Bitcoins since that time. This growth is part of its wider investment plan to establish a contemporary and strong financial system.
In 2021, the company began directly investing corporate profits into Bitcoin. This pattern of regular reinvestment has over the years contributed to the treasury strategy of the company. The latest purchase continues this model, using excess liquidity to fund further Bitcoin acquisitions.
Bitcoin Used to Diversify Treasury Reserves
Evertz Pharma aims to use Bitcoin to diversify its treasury portfolio and manage capital more efficiently. The company believes Bitcoin offers strong liquidity. This allows faster and more cost-effective fund reallocations across departments or projects.
The firm also considers Bitcoin a strategic financial asset. By treating it as part of its capital management, Evertz Pharma plans to reduce dependency on traditional financial instruments. The shift reflects a desire to align operations with digital asset trends without compromising financial discipline.
BTC Seen as Part of Modern Treasury Approach
The company maintains that Bitcoin will play a central role in its treasury outlook moving forward. The strategy focuses on sustainable and scalable asset management. Management emphasized that building a solid Bitcoin reserve is key to its long-term financial health.
By viewing Bitcoin as more than a speculative asset, the firm adopts a forward-looking view. The integration of crypto into treasury operations reflects changes in corporate asset planning. Evertz Pharma sees this as part of adapting to the needs of a modern company.
Comparison to Global Leaders in BTC Treasury
Evertz Pharma has drawn inspiration from companies like MicroStrategy and Japan’s Metaplanet. Though smaller in scale, the pharmaceutical company adopts similar financial strategies centered on Bitcoin. The goal remains to preserve capital and ensure liquidity.
At the time of press, Bitcoin’s value showed a 1.68% decline in 24 hours. The coin traded at around $107,900. Despite minor price dips, Bitcoin’s weekly and monthly performance remains positive.
